✦ LIBER ✦

CS-866 versus losartan, valsartan, and irbesartan in patients with essential hypertension

✍ Scribed by S Oparil; S.G Chrysant; T Marbury; D Williams; J.M Neutel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative Efficacy of Olmesartan, Losa

✍ Suzanne Oparil; David Williams; Steven G. Chrysant; Thomas C. Marbury; Joel Neut 📂 Article 📅 2001 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 985 KB

Comparison of Increasing Doses of Olmesa

✍ Thomas D. Giles; Suzanne Oparil; Tonous N. Silfani; Antonia Wang; J. Findlay Wal 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 290 KB

Valsartan and atenolol in patients with

✍ Cifkova, R; Peleška, J; Hradec, J; Rosolová, H; Pintérová, E; Zeman, K; Oddou-St 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 61 KB

PCV66 Pharmacoeconomic Analysis of Azils

✍ A.J. Zamora Muciño-Arroyo; J.G. Gay-Molina; J. Chiu-Ugalde; A. Figueroa-Rodrigue 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Evaluation of the Dose Response With Val

✍ Matthew R. Weir; Nora Crikelair; Drew Levy; Ricardo Rocha; Venkatram Kuturu; Rob 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 266 KB

Losartan versus valsartan in the treatme

✍ William J. Elliott; David A. Calhoun; Paul T. DeLucca; Lisa P. Gazdick; Dawn E. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 753 KB